IMO the way this process should work:
1. Halt
2. Trial update
3. Modest rights issue with stretch options
4. Resume trade
This assumes trial success, but the bulk of future funding arrives at a significant price differential.
Just have a look at how new entrants at CHM were shafted last Thursday after announcing their trial update and trading for less than 3 hours before announcing another funding round. Some new holders will already be down >50%.
The above process would reward existing shareholders and mitigate dilution without shafting new market participants.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.010(6.67%) |
Mkt cap ! $39.55M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 16.0¢ | 15.0¢ | $50.40K | 325.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53745 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 169335 | 5 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| ILA (ASX) Chart |